Nationally recognized urologic oncologist offers vision for growth, innovation, and excellence
Trained in the use of multiple focal therapies for prostate cancer, Dr. Jamil Syed recommends HIFU for certain patients with intermediate-risk prostate cancer, especially individuals with small, well-defined tumors localized to the lateral and posterior regions of the gland.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement